SJS Investment Consulting’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3
Closed -$43 2891
2026
Q1
$43 Buy
+3
New +$40 ﹤0.01% 2270
2023
Q4
Sell
-7
Closed -$142 1619
2023
Q3
$142 Sell
7
-3
-30% -$68 ﹤0.01% 1504
2023
Q2
$256 Sell
10
-3
-23% -$79 ﹤0.01% 1353
2023
Q1
$387 Buy
13
+3
+30% +$87 ﹤0.01% 1222
2022
Q4
$271 Sell
10
-10
-50% -$245 ﹤0.01% 1359
2022
Q3
$0 Buy
+20
New +$523 ﹤0.01% 1048
2022
Q1
$0 Buy
+1
New +$32 ﹤0.01% 719

Other funds holding AVNS

SJS Investment Consulting's AVNS Position: Q2 2026 in Review

SJS Investment Consulting sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 3 shares — an estimated $43 sold.

SJS Investment Consulting first reported a position in AVNS in Q1 2022 and held it in 7 quarters. The position peaked at $387 in Q1 2023. 73 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • SJS Investment Consulting reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
  • SJS Investment Consulting sold 3 Avanos Medical shares in Q2 2026, an estimated $43.
  • SJS Investment Consulting first reported a position in Avanos Medical in Q1 2022 and held it in 7 quarters.
  • SJS Investment Consulting's Avanos Medical position peaked at $387 in Q1 2023.
  • 73 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.